These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2270318)

  • 1. Insulin-induced hypoglycemia, L-dopa and arginine stimulate GH secretion through different mechanisms in man.
    Masuda A; Shibasaki T; Hotta M; Yamauchi N; Ling N; Demura H; Shizume K
    Regul Pept; 1990 Oct; 31(1):53-64. PubMed ID: 2270318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance between growth hormone (GH) responses after GH-releasing hormone and insulin hypoglycemia in myotonic dystrophy.
    Okimura Y; Chihara K; Kita T; Kashio Y; Sato M; Kitajima N; Abe H; Takahashi K; Fujita T
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1074-9. PubMed ID: 3141449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone does not inhibit its own secretion during prolonged hypoglycemia in man.
    Barbetti F; Crescenti C; Negri M; Leonetti F; Grossi A; Tamburrano G
    J Clin Endocrinol Metab; 1990 May; 70(5):1371-4. PubMed ID: 2110574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects.
    Hanew K; Utsumi A
    Eur J Endocrinol; 2002 Feb; 146(2):197-202. PubMed ID: 11834428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
    Page MD; Dieguez C; Valcavi R; Edwards C; Hall R; Scanlon MF
    Clin Endocrinol (Oxf); 1988 May; 28(5):551-8. PubMed ID: 3145820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant effects of insulin-hypoglycemia on growth hormone (GH)-releasing hormone-stimulated GH and thyrotropin (TSH)-releasing hormone-stimulated TSH secretion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1988 Apr; 66(4):872-5. PubMed ID: 3126217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
    Bondanelli M; Ambrosio MR; Margutti A; Franceschetti P; Zatelli MC; degli Uberti EC
    Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma GH responses to GHRH and insulin-induced hypoglycemia in man.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Demura H; Ling N; Shizume K
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1265-7. PubMed ID: 3923025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases].
    Mitsuhashi S; Yamasaki R; Miyazaki S; Saito H; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):934-46. PubMed ID: 3123283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
    Torronteras R; Gracia-Navarro F; Elsaesser F
    Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man.
    Masuda A; Shibasaki T; Kim YS; Imaki T; Hotta M; Demura H; Ling N; Shizume K
    J Clin Endocrinol Metab; 1989 Oct; 69(4):906-9. PubMed ID: 2506217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia.
    Frohman LA; Downs TR; Clarke IJ; Thomas GB
    J Clin Invest; 1990 Jul; 86(1):17-24. PubMed ID: 1973173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of somatostatin (SRIH) and a SRIH analog, SMS 201-995, on the secretion of growth hormone and thyroid-stimulating hormone in man.
    Williams TC; Kelijman M; Crelin WC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Jan; 66(1):39-45. PubMed ID: 2891721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the cholinergic pathway in growth hormone feedback.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1991 May; 72(5):1081-7. PubMed ID: 1902484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of L-dopa and GHRH on GH secretion in normal men.
    Alba-Roth J; von Creytz C; Mehltretter G; Schopohl J; Müller OA; von Werder K
    J Endocrinol Invest; 1989 Dec; 12(11):783-7. PubMed ID: 2515218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) profiles with successive provocation by GH-releasing hormone and arginine in children: a clinical appraisal.
    Sato T; Igarashi N; Miyagawa K; Shimizu M; Nishikawa T
    Endocrinol Jpn; 1991 Feb; 38(1):33-8. PubMed ID: 1915111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blindness impairs plasma growth hormone response to L-dopa but not to arginine.
    Bellastella A; Parlato F; Sinisi AA
    J Clin Endocrinol Metab; 1990 Apr; 70(4):856-8. PubMed ID: 2318945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.